Sort
326,823 grants matching “clinical trial”
Preclinical Development of LIGO-069-136, An Anti-Inflammatory Pulmonary Therapeut
$1,547,235Robert Frost Bargatze · Takeda Vaccines, Inc. · R44 · FY2008 · AI
Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Data Coordinating Center
$1,547,234James A Tonascia · Johns Hopkins University · U24 · FY2022 · DK
A Caribbean Project for Clinical and Basic Neuroscience Research
$1,547,110Edmundo Nelson Kraiselburd · University Of Puerto Rico Med Sciences · U54 · FY2010 · NS
GMP Production and Extended Toxicology of an Oral Formulation Drug for Alzheimer's Disease
$1,546,977D. Martin Watterson · Northwestern University At Chicago · U01 · FY2022 · AG
Action for Health in Diabetes (Look AHEAD)
$1,546,953David M Nathan · Massachusetts General Hospital · U01 · FY2010 · DK
I-CARE 2 RCT: Mobile Telehealth to Reduce Alzheimer's-related Symptoms for Caregivers and Patients
$1,546,935Richard J Holden · Trustees Of Indiana University · RF1 · FY2025 · AG
Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases
$1,546,926Charlotte Ann Gaydos · Johns Hopkins University · U54 · FY2014 · EB
Glycemic Profile of Pregnancy Consortium Biostatistics Research Center
$1,546,852Denise M Scholtens · Northwestern University At Chicago · U01 · FY2022 · DK
MANUFACTURING OF TPM SUITABLE FOR HUMAN USE
$1,546,809Max Moore · Leidos Biomedical Research, Inc. · N01 · FY2023 · CA
HIV/AIDS Risk Reduction for African American Couples
$1,546,714Nabila El-Bassel · Columbia Univ New York Morningside · U10 · FY2007 · MH
SmartInsulin Stability, Process Development, Assay Validation and GMP Manufacturi
$1,546,698Todd C Zion · Smartcells, Inc. · R44 · FY2008 · DK
DISCOVERY - Recruitment and Retention Core
$1,546,651James F Meschia · Massachusetts General Hospital · U19 · FY2023 · NS
GMP Production and Extended Toxicology of an Oral Formulation Drug for Alzheimer's Disease
$1,546,636D. Martin Watterson · Northwestern University At Chicago · U01 · FY2024 · AG
Non-Contact Point of Care Device for Sleep Studies
$1,546,575John Paul Condon · Innovative Design Labs, Inc. · R44 · FY2025 · AG
Community Clinical Oncology Program Research Base
$1,546,497Walter John Curran · American College Of Radiology · U10 · FY2007 · CA
Comprehensive dissection of the CLL genome & phenome to improve patient outcomes
$1,546,492Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2024 · CA
Early Phase Psychosis: Informing Treatment Decisions
$1,546,469John M Kane · Feinstein Institute For Medical Research · P30 · FY2012 · MH
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$1,546,444Lars F Berglund · University Of California At Davis · UL1 · FY2008 · RR
Androgen Receptor Action in Castration Resistant Prostate Cancer
$1,546,415Steven P. Balk · Beth Israel Deaconess Medical Center · P01 · FY2019 · CA
Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infection
$1,546,361Aileen Chang · George Washington University · U01 · FY2024 · AR
Inhaled GM-CSF Therapy of Autoimmune Pulmonary Alveolar Proteinosis
$1,546,330Sharie Haugabook · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR
Improving Cognition via Exercise in Schizophrenia
$1,546,220David Kimhy · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · MH
Environmental Agents as Modulators of Disease Processes
$1,546,184Thomas A Gasiewicz · University Of Rochester · P30 · FY2011 · ES
Molecular Targets Development Program
$1,546,171James McMahon · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
Understanding and Improving Therapies for the Muscular Dystrophies
$1,546,142Hugh Lee Sweeney · University Of Florida · P50 · FY2024 · AR